Esomeprazole Magnesium is a proton pump inhibitor (S-isomer of omeprazole) indicated for GERD, erosive esophagitis, H. pylori eradication and risk reduction of NSAID-associated gastric ulcer. We supply it to US manufacturers of delayed-release capsules and delayed-release oral suspension.
Data from PubChem (CID 9568613) and FDA’s substance registry
CAS number
161973-10-0
Molecular formula
C34H36MgN6O6S2
Molecular weight
713.1g/mol
FDA UNII
IUPAC name
magnesium bis(5-methoxy-2-[(S)-(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-ide)
InChIKey
KWORUUGOSLYAGD-YPPDDXJESA-N
- Appearance
- White to slightly cream or slightly yellow powder.
- Solubility
- Soluble in methanol. Degrades rapidly in acidic media and is more stable under alkaline conditions.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
Supplied as the trihydrate or the dihydrate, each with its own filing. State which, and agree on temperature-controlled shipping, because it degrades with heat and moisture.
On the US market
- Reference product
- NexiumNDA 021153
- Approved ANDAs
- 38 with a marketed product
- Approved forms and strengths
- Delayed-release capsule (pellets) 20 mg, 40 mg
- Delayed-release granules for oral suspension 2.5 mg per packet, 5 mg per packet, 10 mg per packet, 20 mg per packet, 40 mg per packet
- Delayed-release capsule 20 mg
- Delayed-release tablet 20 mg
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com